HomeLBank Stocks
Veradermics, Incorporated
Veradermics, Incorporated

Veradermics, Incorporated (MANE)

24HHigh$136.7224HLow$110.56
$126.69
+0.14%

Last updated: 2026-10-08 10:12:47

K-Line Chart, actual market data is subject to the trading page.

Key Data

Prev. Open
$111.60
Prev. Close
$126.69
Prev. Day's Range
$110.56 - $136.72
52W Range
$32.00 - $131.24
Trading Volume
3.351M
MC
$4.552B
P/E Ratio
--
EPS
$-4.24

Company Overview

NYSE

Veradermics, Incorporated is a biopharmaceutical company focused on developing novel therapeutics for dermatologic and aesthetic conditions. The company is headquartered in New Haven, Connecticut.

SectorHEALTHCARE
IndustryBIOTECHNOLOGY
Headquarters470 JAMES STREET, NEW HAVEN, CT, UNITED STATES, 06513
CountryUSA
Listing Date2026-02-04
Fiscal Year Ended2026-06-30
Shares Outstanding41.78M
CIK Code

Financial Metrics

Indicator2026-06-302026-03-312025-12-312025-09-30
Income$0$0$0$0
Operating Expenses--------
Net Income-$23.502M-$27.232M-$21.847M-$20.103M
Net Profit Margin--------
Earnings Per Share--------
EBITDA-$29.553M-$27.232M-$21.315M-$19.16M
Effective Tax Rate--------

FAQ

MANE operates in the [sector] sector, focusing on the [specific industry or niche]. The company specializes in [core business activities or products], which are essential for its customers in [key industries served]. Its business model emphasizes [main strategy or unique selling propositions], making it a notable player in its market.
MANE’s revenue primarily comes from [main revenue streams], including [key products, services, or customer segments]. Its growth is driven by [specific factors like market demand, innovation, partnerships, or geographic expansion]. The company’s ability to serve [specific needs or industries] provides a steady source of income.
MANE faces competition from [competitor names] in the [industry name]. These competitors operate in similar markets and offer [mention similar offerings or services]. MANE differentiates itself through [unique strategies, competitive advantages, or market positioning]. Industry competition is based on factors like [e.g., pricing, innovation, customer relationships].
As of now, MANE [does/does not] pay dividends to its shareholders. The company’s dividend policy aligns with its priorities for capital allocation, such as [investment in growth initiatives, debt repayment, or returning value to investors]. Investors should consider this when evaluating its stock for income-generating potential.
Investing in MANE involves risks such as [mention relevant risks like economic conditions, regulatory changes, competition, or operational challenges]. Additionally, the company operates in [specific industry], which might face [specific risk factors like market volatility, changing trends, or cost pressures]. Investors should weigh these risks against the company’s strengths.
MANE has growth opportunities in areas such as [mention specific opportunities like expanding markets, launching new products, or leveraging technology]. The demand for [specific products/services] is increasing, creating potential for revenue growth. However, successfully capitalizing on these opportunities depends on [key factors like execution, strategy, or market conditions].
MANE’s valuation, reflected in metrics like [e.g., P/E ratio, market cap, or other relevant measures], can be compared to peers such as [competitor names]. While valuation fluctuates based on market conditions, it provides insight into how investors perceive MANE relative to others in the [specific industry].
MANE’s long-term prospects depend on its ability to [mention key factors like adapt to industry trends, innovate, or expand its market presence]. While the company has [specific strengths or opportunities], risks such as [mention relevant risks] could impact its performance. Investors should consider both its potential and challenges.
Risk Warning
  1. 1.Stock prices may fluctuate significantly; invest with caution. Past performance is not indicative of future results.
  2. 2.Digital asset trading involves multiple risks, including market and technical risks. Please make rational decisions and allocate assets wisely.
  3. 3.The information contained on this page is for reference only and does not constitute any investment advice.